top
Please input keywords
News events
Contact us
EN
CN
JP
KR
About us
Introduction
History
Management team
Culture
Social Responsibility
Join us
Collaborations
Antibody Assets
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
Animal Models
Humanized animal models
KO mouse models
Tool mice
Immunodeficient mice/rats
Cell lines
Aged mice
Disease mouse models
Pharmacology Service
Therapeutic area
Types of services
Molecule type
Technology
Gene Editing
By species
By technologies
By strategies
Animal Breeding
Animal Cryopreservation
Animal Rederivation
Other Services
Microbial detection
Animal Breeding
Animal Cryopreservation
Animal Rederivation
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
News events
News
Media Center
News
Events
Webinar
Publication
Downloads
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
2024.12.16
Join Us at Booth #212 and Explore Our Poster at AET-US 2024!
2024.12.11
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
2024.11.11
Year
All
2024
2023
2022
2021
Month
All
January
February
March
April
May
June
July
August
September
October
November
December
+86-010-56967680
info@bbctg.com.cn
010-56967601
ir@bbctg.com.cn
Copyright © 2024 Biocytogen. All Rights Reserved
Powered by Fractal-technology